Literature DB >> 25171312

Resolution of cystic fibrosis-related diabetes with ivacaftor therapy.

Don Hayes1, Karen S McCoy, Shahid I Sheikh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25171312     DOI： 10.1164/rccm.201405-0882LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  28 in total

1.  Is Cystic Fibrosis-related Diabetes Reversible? New Data on CFTR Potentiation and Insulin Secretion.

Authors:  Andrew W Norris
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

2.  Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy.

Authors:  Andrea Kelly; Diva D De Leon; Saba Sheikh; Devaney Camburn; Christina Kubrak; Amy J Peleckis; Darko Stefanovski; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

Review 3.  Novel and Experimental Therapies in Chronic Pancreatitis.

Authors:  Soumya Jagannath; Pramod Kumar Garg
Journal:  Dig Dis Sci       Date:  2017-05-27       Impact factor: 3.199

4.  Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis.

Authors:  Yaling Yi; Andrew W Norris; Kai Wang; Xingshen Sun; Aliye Uc; Antoinette Moran; John F Engelhardt; Katie Larson Ode
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

Review 5.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

6.  Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

Authors:  Drucy Borowitz; Barry Lubarsky; Michael Wilschanski; Anne Munck; Daniel Gelfond; Frank Bodewes; Sarah Jane Schwarzenberg
Journal:  Dig Dis Sci       Date:  2015-08-07       Impact factor: 3.199

Review 7.  New and emerging targeted therapies for cystic fibrosis.

Authors:  Bradley S Quon; Steven M Rowe
Journal:  BMJ       Date:  2016-03-30

Review 8.  Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.

Authors:  Marcus A Mall; Nicole Mayer-Hamblett; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

9.  Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor.

Authors:  Angel Li; Tim Vigers; Laura Pyle; Edith Zemanick; Kristen Nadeau; Scott D Sagel; Christine L Chan
Journal:  J Cyst Fibros       Date:  2018-08-10       Impact factor: 5.482

10.  Cystic Fibrosis Related Diabetes: a Unique Challenge in Diabetes Care.

Authors:  Marina Litvin; Schola Nwachukwu
Journal:  Mo Med       Date:  2016 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.